210 related articles for article (PubMed ID: 33419765)
21. Role of MyD88 signaling in the imiquimod-induced mouse model of psoriasis: focus on innate myeloid cells.
Costa S; Marini O; Bevilacqua D; DeFranco AL; Hou B; Lonardi S; Vermi W; Rodegher P; Panato A; Tagliaro F; Lowell CA; Cassatella MA; Girolomoni G; Scapini P
J Leukoc Biol; 2017 Sep; 102(3):791-803. PubMed ID: 28642279
[TBL] [Abstract][Full Text] [Related]
22. IL-12 regulates type 3 immunity through interfollicular keratinocytes in psoriasiform inflammation.
Zwicky P; Ingelfinger F; Silva de Melo BM; Ruchti F; Schärli S; Puertas N; Lutz M; Phan TS; Kündig TM; Levesque MP; Maul JT; Schlapbach C; LeibundGut-Landmann S; Mundt S; Becher B
Sci Immunol; 2021 Oct; 6(64):eabg9012. PubMed ID: 34678045
[TBL] [Abstract][Full Text] [Related]
23. Isogarcinol Extracted from Garcinia mangostana L. Ameliorates Imiquimod-Induced Psoriasis-like Skin Lesions in Mice.
Chen S; Han K; Li H; Cen J; Yang Y; Wu H; Wei Q
J Agric Food Chem; 2017 Feb; 65(4):846-857. PubMed ID: 28081600
[TBL] [Abstract][Full Text] [Related]
24. MALT1 Proteolytic Activity Suppresses Autoimmunity in a T Cell Intrinsic Manner.
Demeyer A; Skordos I; Driege Y; Kreike M; Hochepied T; Baens M; Staal J; Beyaert R
Front Immunol; 2019; 10():1898. PubMed ID: 31474984
[TBL] [Abstract][Full Text] [Related]
25. Loss of keratinocyte Mcpip1 abruptly activates the IL-23/Th17 and Stat3 pathways in skin inflammation.
Lichawska-Cieslar A; Konieczny P; Szukala W; Declercq W; Fu M; Jura J
Biochim Biophys Acta Mol Cell Res; 2021 Jan; 1868(1):118866. PubMed ID: 33007332
[No Abstract] [Full Text] [Related]
26. p38α signaling in Langerhans cells promotes the development of IL-17-producing T cells and psoriasiform skin inflammation.
Zheng T; Zhao W; Li H; Xiao S; Hu R; Han M; Liu H; Liu Y; Otsu K; Liu X; Huang G
Sci Signal; 2018 Mar; 11(521):. PubMed ID: 29535261
[TBL] [Abstract][Full Text] [Related]
27. Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation.
Ma L; Xue H; Qi R; Wang Y; Yuan L
J Transl Med; 2018 Mar; 16(1):59. PubMed ID: 29523162
[TBL] [Abstract][Full Text] [Related]
28. Interleukin 17 Promotes Expression of Alarmins S100A8 and S100A9 During the Inflammatory Response of Keratinocytes.
Christmann C; Zenker S; Martens L; Hübner J; Loser K; Vogl T; Roth J
Front Immunol; 2020; 11():599947. PubMed ID: 33643287
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-146a suppresses IL-17-mediated skin inflammation and is genetically associated with psoriasis.
Srivastava A; Nikamo P; Lohcharoenkal W; Li D; Meisgen F; Xu Landén N; Ståhle M; Pivarcsi A; Sonkoly E
J Allergy Clin Immunol; 2017 Feb; 139(2):550-561. PubMed ID: 27568078
[TBL] [Abstract][Full Text] [Related]
30. Astilbin inhibits Th17 cell differentiation and ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice via Jak3/Stat3 signaling pathway.
Di TT; Ruan ZT; Zhao JX; Wang Y; Liu X; Wang Y; Li P
Int Immunopharmacol; 2016 Mar; 32():32-38. PubMed ID: 26784569
[TBL] [Abstract][Full Text] [Related]
31. CARD14/CARMA2 Signaling and its Role in Inflammatory Skin Disorders.
Zotti T; Polvere I; Voccola S; Vito P; Stilo R
Front Immunol; 2018; 9():2167. PubMed ID: 30319628
[TBL] [Abstract][Full Text] [Related]
32. Psoriasiform dermatitis is driven by IL-36-mediated DC-keratinocyte crosstalk.
Tortola L; Rosenwald E; Abel B; Blumberg H; Schäfer M; Coyle AJ; Renauld JC; Werner S; Kisielow J; Kopf M
J Clin Invest; 2012 Nov; 122(11):3965-76. PubMed ID: 23064362
[TBL] [Abstract][Full Text] [Related]
33. Stat3 activation in epidermal keratinocytes induces Langerhans cell activation to form an essential circuit for psoriasis via IL-23 production.
Nakajima K; Kataoka S; Sato K; Takaishi M; Yamamoto M; Nakajima H; Sano S
J Dermatol Sci; 2019 Feb; 93(2):82-91. PubMed ID: 30514663
[TBL] [Abstract][Full Text] [Related]
34. Pentacyclic triterpene compounds from loquat leaves reduce skin inflammation and epidermal hyperplasia in psoriasis via inhibiting the Th17 cells.
Tian X; Tang L; Wei F; Chen H; Sheng L; Yang Y; Zhou X; Li Y; Xu X; Zhang B; Liu Z; Lei Y; Yu B; Bai C; He X; Huang Z
Mol Immunol; 2021 Apr; 132():30-40. PubMed ID: 33540227
[TBL] [Abstract][Full Text] [Related]
35. A CARD10-Dependent Tonic Signalosome Activates MALT1 Paracaspase and Regulates IL-17/TNF-α-Driven Keratinocyte Inflammation.
Israël L; Bardet M; Huppertz A; Mercado N; Ginster S; Unterreiner A; Schlierf A; Goetschy JF; Zerwes HG; Roth L; Kolbinger F; Bornancin F
J Invest Dermatol; 2018 Sep; 138(9):2075-2079. PubMed ID: 29571942
[No Abstract] [Full Text] [Related]
36. Biological Effects of IL-26 on T Cell-Mediated Skin Inflammation, Including Psoriasis.
Itoh T; Hatano R; Komiya E; Otsuka H; Narita Y; Aune TM; Dang NH; Matsuoka S; Naito H; Tominaga M; Takamori K; Morimoto C; Ohnuma K
J Invest Dermatol; 2019 Apr; 139(4):878-889. PubMed ID: 30423328
[TBL] [Abstract][Full Text] [Related]
37. Targeting interleukin-22 in psoriasis.
Hao JQ
Inflammation; 2014 Feb; 37(1):94-9. PubMed ID: 23978911
[TBL] [Abstract][Full Text] [Related]
38. Keratinocytes regain momentum as instigators of cutaneous inflammation.
Nickoloff BJ
Trends Mol Med; 2006 Mar; 12(3):102-6. PubMed ID: 16443394
[TBL] [Abstract][Full Text] [Related]
39. The IL-23/IL-17 Pathway in Inflammatory Skin Diseases: From Bench to Bedside.
Liu T; Li S; Ying S; Tang S; Ding Y; Li Y; Qiao J; Fang H
Front Immunol; 2020; 11():594735. PubMed ID: 33281823
[TBL] [Abstract][Full Text] [Related]
40. Anti-IL-12/IL-23p40 antibody ameliorates dermatitis and skin barrier dysfunction in mice with imiquimod-induced psoriasis-like dermatitis.
Takahashi T; Koga Y; Kainoh M
Eur J Pharmacol; 2018 Jun; 828():26-30. PubMed ID: 29544684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
